HIV/AIDS Research
Annexin II may be new target for prevention of HIV-1 infection
Published in Blood Weekly, February 24th, 2005
"The distribution of secretory leukocyte protease inhibitor (SLPI) at entry portals indicates its involvement in defending the host from pathogens, consistent with the ability of SLPI to inhibit human immunodeficiency virus (HIV)-1 infection by an unknown mechanism.
"We now demonstrate that SLPI binds to the membrane of human macrophages through the phospholipid-binding protein, annexin II," wrote investigators from the United States.
"Based on the recent identification of human cell membrane phosphatidylserine (PS) in the outer coat of HIV-1," G. Ma and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-02-24)
More Articles from Blood Weekly
- Biomedical Engineering
Mandible reconstruction with bone grafts/platelet rich plasma is effective - Neural Stem Cell Research
Neural stem cell generation of dopaminergic neurons is enhanced by Bcl-X-L - Stem Cell Therapy
Stem cell therapy may be used to treat neurotrauma - Stem Cell Transplantation
Lenograstim reduces infection incidence until neutrophil recovery after SCT - Tissue Engineering
Importance of functional innervation demonstrated in tissue engineered models - Acute Myeloid Leukemia
Elevated AFlq gene expression is an independent adverse prognostic factor in AML - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
